spacer
home > ict > winter 2009 > informed integration
PUBLICATIONS
International Clinical Trials

Informed Integration

The biopharmaceutical industry has benefited substantially in recent years from a wide range of eClinical solutions, including electronic data capture (EDC), interactive voice and web response systems (IVRS/IWRS), clinical trial management systems (CTMS), clinical data management systems (CDMS), medical imaging, lab software and electronic patient reported outcomes (ePRO) solutions. While these technologies have significantly improved efficiency and data quality within specific parts of the clinical development process, there remains throughout the industry a critical need to improve the ability to share information and reduce redundant data entry across the clinical enterprise. This lack of data integration and interoperability is preventing biopharmaceutical companies from reaping even greater rewards from their technology systems, such as improved support for ‘go/no-go’ decisions, greater trial productivity and faster product development.

It is apparent that the adoption of eClinical technologies needs to keep pace with the rapid evolution in the global marketplace of biopharmaceutical products. The industry faces an array of challenges, including mounting pressure to improve product development processes, and bring innovative compounds to market more quickly, significantly higher development costs, and growing regulatory demands, especially the need to increase drug safety.

To improve the productivity and efficiency of clinical trials, biopharmaceutical companies must accelerate their implementation of the next generation of eClinical systems and leverage available technologies to better integrate their trial data. While these technology improvements can present their own challenges, the demands of today’s complex healthcare environment make data integration improvements absolutely vital. With greater strategic access to integrated trial information, biopharmaceutical companies will be able to make better development decisions, eliminate inefficient redundancies, reduce trial delays, improve patient safety and speed up time to market.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
David Stein is Perceptive Informatics’ Senior Director of Product Management and plays a pivotal role in managing the company’s products and services, as well as developing new technology solutions to improve the clinical trials process. Prior to joining Perceptive Informatics in 2002, David worked in Strategic Business Development and Marketing at PhaseForward. He also founded, and later sold, an electronic patient reported outcomes company. Earlier in his career, he established and managed the data management department for a mid-sized contract research organisation. David has also served as an independent consultant in the field of pharmaceutical technologies, and has co-developed several custom software packages.

 

spacer
David Stein
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Signant Health Launches Partner Program to Team with Clinical Research Organizations (CROs) Committed to Improving Clinical Trials with Patient-Centric Technology

PHILADELPHIA – August 12, 2019: Signant Health (signanthealth.com), a leading provider of technology for clinical research, today launches the Signant Health Partner Program, a significant investment the company is making to enable clinical research organizations (CROs) to better serve sponsors in the areas of Patient Data, Patient Experience, Clinical Supplies, and Endpoint Quality Solutions. By becoming a Signant Partner, CROs will benefit from new commercial and operational advantages that only come with membership.
More info >>

White Papers

Faster, Better, Cheaper: Lean as a Driving Force Behind Pharmaceutical Companies’ Growth

TBM Consulting Group

The pharmaceutical industry faces countless challenges: patent expirations, weak product development pipelines, downward pricing pressure and an increasingly burdensome regulatory environment. The most important question for companies is now “How can we position ourselves optimally to be successful in the long term?” Some pharmaceutical companies used the economic downturn in 2009 to embrace measures in the fields of cost reduction and efficiency increases, which can be implemented at short notice. The continuous and consistent implementation of sustainable measures that guarantee stability and form the basis for future growth was not necessarily paramount within this.
More info >>

 
Industry Events

CPhI Worldwide

5-7 November 2019, Frankfurt, Germany

Join the World's Largest Pharma Event As it Celebrates its 30th Anniversary! Taking place from 5-7 November 2019 in Frankfurt, Germany, the event will bring together more than 45,000 visiting pharma professionals from around the globe and over 2,500 exhibiting pharma companies from every stage of the pharmaceutical supply chain - from ingredients and machinery to outsourcing services, packaging and more!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement